Beijing BRD Lixin PharmaTech

Beijing BRD Lixin PharmaTech was a pharmaceutical consulting and development services company based in Beijing, China. Founded in 2005, the company specialized in providing regulatory consulting, Good Manufacturing Practice (GMP) compliance training, and pharmaceutical development services to domestic and international biotech and pharmaceutical firms. In 2007, the company entered into a significant joint venture with the Canadian firm PharmEng International, which acquired a 51% controlling interest to form Beijing PharmEng BRD Lixin PharmaTech Consultation Co. Ltd. The firm played a key role in bridging international regulatory standards with the Chinese pharmaceutical market during the mid-2000s.